Patent · US Active

Antibodies against clostridium difficile toxins and methods of using the same

US12116402B2 · kind B2 · utility

0Cited by

4References

4Claims

0Family size

Assignee

Sanofi Pasteur, Inc. · US

Inventors

Stephen Anderson · Buckshaw Village, GB
Natalie Anosova · Lexington, US
Nicola Beltraminelli · L'Essart Mador, FR
Pierre Garrone · Val-de-Reuil, FR
Harold Kleanthous · Westford, US
Majid Mehtali · Strasbourg, FR
Jianxin Zhang · Acton, US

Key dates

Filing date	Nov 30, 2021
Grant date	Oct 15, 2024
Priority date	—
Expiry date	Jun 1, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Monoclonal antibodies, or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.